Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hypoxic tissue refers to regions within the body where oxygen levels are abnormally low, resulting in insufficient oxygen supply to meet cellular metabolic demands. This state triggers a range of adaptive and pathological responses, primarily mediated by hypoxia-inducible factors (HIFs). Persistent or severe tissue hypoxia contributes to various pathologies including ischemic injury, tumor progression, and inflammatory diseases.
Drugs that interfere with the HIF pathway (e.g., HIF-alpha stabilization/degradation, HIF dimerization), or target downstream effects like angiogenesis induced by hypoxia
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hypoxic Tissue.